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Abstract The central circadian oscillator of the suprachias-
matic nucleus controls diurnal rhythmicity of the body with light
as its dominant zeitgeber. Recently, peripheral oscillators have
been detected in liver and heart, which follow as yet unidenti¢ed
cues. In this study real-time reverse transcription-polymerase
chain reaction (RT-PCR) was used in analysis of the expression
of the major clock genes Per1, Per2, Bmal1, Cry1, Tim (time-
less) and Clock, as well as of the output genes Dbp and Rev-
erbK in the pancreatic tissue of rats. The results presented here
indicate a robust circadian expression of clock genes (e.g. Per1
and Bmal1) and the probable existence of a peripheral oscillator
in the pancreas. Whether this oscillator regulates the diverse
functions of the islets of Langerhans remains to be elucidated.
( 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
In mammals the central circadian pacemaker of the supra-
chiasmatic nucleus (SCN) comprises two intertwining feed-
back loops, with BMAL/CLOCK as the driving components
of the positive limb and CRY/PER heterodimers as compo-
nents of the negative limb. The genes of CRY/PER are acti-
vated by BMAL/CLOCK and repress this activation at the
end of each circadian cycle [1,2]. Light is the zeitgeber for the
central circadian oscillator (CCO), which couples internal
rhythms to the objective day/night patterns [3,4].
Recent research, however, indicates that, besides the central
clock of the brain, peripheral oscillators exist in several or-
gans, such as the heart [5,6], liver [7,8], kidney [9], oviduct [10]
and hypophyseal pars tuberalis [11]. Di¡erences in circadian
phase distribution suggest tissue-speci¢c circadian clock regu-
lation. There is evidence that a circadian oscillator could even
function on a cellular level [12^14]. In contrast to the CCO,
factors other than light entrain the rhythm of peripheral or-
gans which can be uncoupled from the ‘master clock’, for
example, by restricted feeding [7,15]. These factors are as
yet unknown; however, glucocorticoids [7,16], glucose [14],
melatonin [17] and other humoral factors, probably speci¢c
for each organ, entrain tissue-speci¢c oscillations. Besides the
central, activity-dominating rhythm generator of the SCN,
‘peripheral clocks’, e.g. in the liver and pancreas, are evolu-
tionarily conserved mechanisms, which enable the organisms
to anticipate, for example, changes in glucose levels due to
food intake [18]. Whether disturbances of pancreatic oscilla-
tions are part of the complex events leading to diabetes is an
open question, but the onset of diabetes mellitus has been
associated with a loss of diurnal rhythmicity in insulin secre-
tion [19].
Peschke and Peschke [17] determined that insulin from iso-
lated rat islets is released in a circadian manner (d between 22
and 26 h) and is in£uenced by melatonin as a zeitgeber. De-
lattre et al. [19] speculated that adenosine triphosphate (ATP)
oscillations might be the underlying mechanism for circadian
insulin release. In order to elucidate the basis for pancreatic
circadian oscillations we studied changes in the expression of
the following clock genes on the transcriptional level: Clock,
Per1, Per2, Cry1, Tim and Bmal1 during a 24-h period by
real-time reverse transcription-polymerase chain reaction
(RT-PCR). In addition, circadian transcript changes of the
clock-controlled output genes Dbp and Rev-erbK [20,21]
were monitored. The ¢ndings of this study suggest the func-
tion of a circadian pacemaker in the rat pancreas. Further-
more, we show evidence for a circadian oscillator in the islets.
2. Materials and methods
2.1. Animals and cells
Male Wistar rats (age: 44 days) were caged individually and sub-
jected to a lighting regime of light:dark= 12 h:12 h, light on: 6:00
a.m. Rats were fed a standard diet ad libitum. Four animals per time
point were killed in a deep anesthesia at 3-h intervals. Tissue sampling
proceeded under red light during the dark phase. Animals were
treated according to German animal welfare regulations throughout
the sampling procedure.
For high-serum treatment, INS1 rat insulinoma L-cells (kindly pro-
vided by C.B. Wollheim, University Medical Center, Geneva, Switzer-
land) were incubated with 50% horse serum in RPMI 1640 medium
(Biochrom KG, Berlin, Germany) for 1 h after preincubation of the
cells in serum-free medium overnight. Cell sampling proceeded 20 h
after serum shock treatment.
2.2. RNA extraction and RT
RNA was extracted from pancreata immersed in RNAlater (Am-
bion Inc., TX, USA) immediately after killing, using a Trizol-based
extraction method according to the manufacturer’s instructions (Invi-
trogen, CA, USA). To extract RNA from the islets, they were sepa-
rated from exocrine tissue by collagenase treatment and collected as
described by Peschke and Peschke [17]. Exocrine tissue cells and islets
were extracted immediately. Total RNA concentrations were deter-
mined by spectrophotometry at 260 nm, and total RNA quality was
assessed by electrophoresis on 1.3% denaturing formaldehyde agarose
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gels. For the elimination of residual DNA, total RNA was subse-
quently subjected to DNase 1 digestion (DNA-free1, Ambion Inc.,
TX, USA). Total RNA (1 Wg) was reverse transcribed using an RT kit
from Promega (Promega Inc., WI, USA) according to the manufac-
turer’s protocols.
2.3. Real-time RT-PCR
For real-time RT-PCR, 40 ng of cDNA was used per reaction.
Primers and sequences are listed in Table 1. Primers were intron
spanning with the exception of Per2, Dbp and Rev-erbK primers.
Each reaction volume of 20 Wl contained 10 Wl of a reaction mix
(Promega Inc., WI, USA), 0.5 Wl of each primer (25 pmol/Wl), 0.5 Wl
of Sybr green I at 103-fold dilution (Biozym Diagnostic GmbH, Hes-
sisch-Oldendorf, Germany) and 4.5 Wl of H2O. PCR was performed
using a rotor cycler (Rotor-Gene 2000, Corbett Research Inc.; Mort-
lake, NSW, Australia) and the following thermopro¢le: initial dena-
turation at 95‡C for 120 s, 40 cycles with 30 s denaturation at 94‡C,
30 s annealing at 59‡C (touchdown from 64‡C with a 1‡C decrease per
cycle) and 30 s elongation at 72‡C. At the end of each elongation step
£uorescence was determined for 15 s at a temperature of 80‡C. For
amplicon analysis a thermal denaturation pro¢le was generated after
each run. The PCR products were further analyzed by separation on
Tris^acetate^ethylenediamine tetraacetic acid (EDTA) bu¡er (TAE)-
bu¡ered 3% agarose gels (pH 8.0) and subsequent ethidium bromide
staining. Quanti¢cation of mRNA was achieved using Corbett Re-
search software, comparing £uorescence intensities at a threshold level
(Ct values) within the logarithmic range of the ampli¢cation curve
[22]. L-Actin expression was used for normalization of target gene
values throughout the experiments. Reaction e⁄ciency was between
0.80 and 0.92 for target gene ampli¢cation, and 0.82 for the house-
keeping gene L-Actin. E⁄ciency was calculated for each primer set
from runs with serial 10-fold cDNA dilutions by using Corbett Re-
search software. The levels of L-Actin mRNA in the pancreas did not
vary signi¢cantly as a function of time of day in accordance with
observations of Damiola et al. [15]. Identity of the PCR products
was veri¢ed by sequencing on a Perkin Elmer ABI 377 sequencer
(Perkin Elmer, Applied Biosystems Inc., CT, USA). Control PCRs
were performed using PCR reaction mix including primers without
cDNA (non-template control) or with 1 Wg of total RNA in the re-
action mixture (control for DNA carryover).
2.4. Western blot
Western blots were performed as described by Mu«hlbauer et al.
[23] using 25 Wg of total pancreatic protein per lane. Polyclonal
anti-mouse Per1 antibody (Per1 PA1^524) was obtained from ABR
(A⁄nity BioReagents, CO, USA) and used at a 1:1000 dilution. For
pre-absorption control experiments, testing signal speci¢city, the pep-
tide with the original antibody epitope SLADDTDANSNG (ABR-
PEP-076-C050; ABR, CO, USA) was used as described by the man-
ufacturer.
2.5. Statistical analysis
For statistical evaluation of results and signi¢cance testing of group
di¡erences, the non-parametric Mann^Whitney U-test was performed
using GraphPad software (GraphPad Software Inc., CA, USA).
Groups were considered to be signi¢cantly di¡erent at P6 0.05.
Data are presented as meansWS.E.M. of four animals per group un-
less otherwise indicated.
3. Results
3.1. Real-time RT-PCR
Analysis of the expression of circadian clock components
indicates circadian oscillation of Per1 mRNA (Fig. 1A). A
maximum of expression was observed at circadian time (CT)
11 (5:00 p.m.). The expression level was 13 times higher than
that of CT 2, the time of minimum expression. Per2 mRNA
analysis demonstrates low-level expression from CT 2 to CT
8, followed by a strong (approximately 4.3-fold) increase in
expression at CT 11, and with a high level of expression
throughout the night times (Fig. 1B). Cry1, as one of the
predominant e¡ectors of the negative limb of the circadian
cycle, was expressed at a low level between CT 2 and CT 8,
followed by an increase during the late day and at night, with
a 10-fold higher level at CT 23 compared to the minimum at
CT 8 (Fig. 1C). Bmal1, determining the positive part of the
feedback loop (together with Clock) of the circadian cycle,
was found to be expressed reverse to Per1. A minimum
Bmal1 transcript level was measured at CT 14 and two max-
ima at CT 2 and CT 23 (Fig. 1D), thus forming a trough-
shaped curve. We did not ¢nd evidence for cyclic expression
of Clock or Tim (timeless), however, in rat pancreas (Fig. 1E
and F). Both genes thus appear either to be constitutively
expressed in the pancreas or to oscillate with a very low am-
plitude below statistical signi¢cance.
One of the output genes of the pancreatic oscillator, Dbp
(Fig. 2A), revealed an expression pro¢le in parallel to Per1,
with an expression maximum at CT 11 and a 28-fold higher
expression level compared to the minimum at CT 2. A similar
pro¢le, but with an even higher amplitude (46-fold di¡erence
between minimum expression at CT 2 and the maximum at
CT 11), was observed for Rev-erbK, a member of the nuclear
orphan receptor family (Fig. 2B) [24].
Table 1
Name Primer sequence Primer site Product length
(bp)
Citation GenBank acc.
no.
Clock forw. 5P-AAGTTAGGGCTGAAAGACGGCG-3P 1139^1160 173 [33], modi¢ed NM021856
rev. 5P-TGAGCTTCTGGAGGAGGCAGAAG-3P 1289^1311
Per-1 forw. 5P-CCAGGCCCGGAGAACCTTTTT-3P 41^60 403 [34] AB002108
rev. 5P-CGAAGTTTGAGCTCCCGAAGT-3P 421^442
Per-2 forw. 5P-GCAGCCTTTCGATTATTCTC-3P 1267^1287 97 [5] AB016532
rev. 5P-GCTCCACGGGTTGATGAAG-3P 1345^1364
Bmal1 forw. 5P-AGATTGAAAAGAGGCGTCGGGA-3P 642^663 382 [35], modi¢ed NM007489
rev. 5P-TCCTTAACTTTGGCAATATC-3P 1004^1023
Cry-1 forw 5P-AGTTCCCCTCCCCTTTCTCTT-3P 1156^1176 101 [36] AF156986
rev. 5P-GGGTTCCCTTCCATTTTGTCA-3P 1236^1256
Dbp forw. 5P-CCGTGGAGGTGCTAATGACCT-3P 960^980 105 [36] J03179
rev. 5P-CCTCTGAGAAGCGGTGCCT-3P 1046^1064
L-Actin forw. 5P-ACTCCTACGTGGGCGACGAGG-3P 152^172 389 (U. Mussho¡, n.p.) NM031144
rev. 5P-CAGGTCCAGACGCAGGATGGC-3P 520^540
Tim forw. 5P-GGAGAAAGCTCAGCAACATGATGA-3P 1206^1229 164 [33] modi¢ed NM031340
rev. 5P-TCAGCTCATAGTAGTTGGTGAGG-3P 1347^136
Rev-erbK forw. 5P-ACAGCTGACACCACCCAGATC-3P 516^536 101 [10] M25804
rev. 5P-CATGGGCATAGGTGAAGATTTCT-3P 594^616
n.p. = not published.
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Besides whole-organ pancreatic extracts, clock gene expres-
sion is detectable in isolated pancreatic islets, exocrine tissue
and INS1 rat insulinoma cells, as indicated by Fig. 3. Hypo-
thalamic expression served as a positive control. Gel electro-
phoretic separation of RT-PCR products revealed speci¢c
transcript occurrence in pancreatic islets and exocrine tissue
as well as L-cells (INS1 insulinoma cells). The output genes
Dbp and Rev-erbK were expressed in all cell types as well ;
speci¢c PCR products were detected in islets, exocrine tissue
and INS1 cells (Fig. 3, bottom).
3.2. Western blot experiments
PER1 expression was con¢rmed by Western blot experi-
ments detecting a speci¢c major band at approximately 45
kDa in high serum-treated INS1 cells, which was suppressible
after incubation of the antibody with the peptide against
which the antibody was raised (+P, Fig. 2C, left). Bands of
similar molecular weight appeared in rat (R) and mouse (M)
pancreatic tissue which was described as the nuclear isoform
of the protein by Chilov et al. ([25], Fig. 2C, middle) who used
the same N-terminus-targeted antibody for PER1 detection in
liver and kidney. They also detected a 55-kDa isoform in these
organs which might correspond with the higher molecular
weight weak band of similar molecular size in INS1 cells
(Fig. 2C, left). The pancreatic signal could be suppressed in
pre-absorption experiments with the epitope (Fig. 2C, right).
Fig. 1. Circadian expression patterns of clock genes in the rat pancreas. Quantitative real-time RT-PCR results of four animals per time point
(unless otherwise stated). Data are expressed as meansWS.E.M. CT 0 was de¢ned as light on. A: Circadian changes of Per1 mRNA abun-
dance. B: Circadian oscillation of Per2 mRNA. C: The circadian expression pattern of the clock gene Cry1. D: The Bmal1 mRNA accumula-
tion pattern is opposite that of Per1 transcripts in rat pancreas (n=6 animals for time points 2, 5 and 23). E, F: The transcripts of the clock
genes Clock and Tim in rat pancreas are not in£uenced by the time of the day. Statistical analysis was performed by Mann^Whitney U-test.
Open squares: time points with light on; ¢lled squares: time points with light o¡; asterisks: statistical di¡erences between time points at
P6 0.05.
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4. Discussion
Rhythmic insulin release from pancreatic L-cells is a well-
known phenomenon [26]. Diurnal rhythmicity of islets has
been suggested to play a role in insulin secretion [27] and
has been proven to occur in isolated rat islets [17,19]. The
latter authors speculated that the circadian oscillator might
regulate insulin release via neural signaling, a concept based
on the earlier work of Sakaguchi et al. [28]. The data of
Peschke and Peschke on rat islets [17], however, pointed out
the existence of an islet-located circadian pacemaker. The
present study was aimed at elucidating the molecular mecha-
nisms of the putative pancreatic oscillator. To this end we
have analyzed clock gene transcript levels of the six major
factors: Clock, Per1, Per2, Tim, Bmal1 and Cry1 during a
24-h period. Changes of expression levels, particularly of
Per1 and Bmal1 but also of Per2, signal the existence of a
circadian oscillator in the rat pancreas.
The presence of PER1 in rat and murine pancreatic tissues
as a V45-kDa protein indicates a translation product of low
molecular size. This protein is of the same molecular size as
the PER1 identi¢ed in liver and brain by Chilov et al. [25]
who presumed this to be a nuclear form. In INS1 insulinoma
cells, PER1 was detected as a major band in serum-treated
cells at approximately 45 kDa, together with a weak band at
approximately 60 kDa; both were suppressible by the control
peptide. As originally observed by Balsalobre et al. [12] serum
shock leads to induction of clock genes. We assume that the
roughly 45-kDa-sized major band also represents the nuclear
form in INS1 cells, in accordance with the predominant 45-
kDa form which is found in pancreatic tissue. The apparently
larger protein in INS1 cells compared to that in pancreas cells
might be due to di¡erences in phosphorylation leading to a
greater molecular mass in the L-cell line [29].
The characteristic antiphase expression pro¢les of Per1 and
Bmal1, which were described for the SCN [2] but also for
peripheral tissues [9,5] were also characteristic of the pancre-
atic oscillator in this study. The Per1 transcript maximum at
CT 11 largely overlaps with trough values for Bmal1 expres-
sion at CT 11 and CT 14. This observation is in accordance
with the proposed functions of the PAS transcription factors
PER1 and BMAL1 within their respective feedback loops
[2,21]. Clock and Tim did not show a clear circadian rhythm
in the pancreas which is in accord with results of others [4],
although Young et al. [5] and Preitner et al. [21] reported a
low-amplitude circadian rhythmicity for Clock in heart and
liver, respectively. Cry1 transcripts, the translation products
of which are known to be the dimerization partner of PER,
were reported to be rhythmic in the SCN [1] and heart,
although with low amplitude in the heart [6] and seem to be
Fig. 2. Circadian expression patterns of the clock-controlled output genes Dbp and Rev-erbK. Quantitative real-time RT-PCR results of four an-
imals per time point. All data are expressed as meansWS.E.M. A: Circadian oscillation of Dbp, with maximum expression at CT 11. B: Rev-
erbK expression is parallel to that of Dbp (and Per1) in the rat pancreas, however, with a very high amplitude and a transcript peak at CT 11.
Statistical analysis was performed by Mann^Whitney U-test (open squares: time points with light on; ¢lled squares: time points with light o¡;
asterisks: statistical di¡erences between time points at P6 0.05). C: Western blot detection of PER1 in high serum-treated INS1 rat insulinoma
L-cells. Left lanes indicate occurrence of a major band at V45 kDa, which was suppressible in a pre-absorption experiment by control peptide
with the epitope (+P). Western blot detection of PER1 protein in pancreatic tissues of rat (R) and mouse (M; middle lanes) demonstrates the
existence of a major band at approximately 45 kDa; this likely signi¢es the presumed nuclear form of PER1 [25]. Pre-absorption experiments
with control peptide demonstrate signal suppression (right lanes: control (C); pre-absorption (+P)).
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rhythmic in the pancreas as well according to our results. The
Cry1 and Per2 expression maxima at night were also observed
by Preitner et al. in the mouse liver [21] ^ a very similar
pattern as detected in the pancreas. One of the clock-con-
trolled output genes, namely the transcription factor Dbp
[20], was found to oscillate in rat pancreas with a large am-
plitude, in accordance with previous results from others on
liver, kidney, muscle, lung [15,9] and heart [5]. Con¢rming our
results, a study on mice SCN from Yamaguchi et al. [30]
describes Dbp oscillation to be in phase with Per1 expression.
These authors also propose a role for Dpb within the circa-
dian core clock mechanism besides its function as an output
recipient. Damiola et al. [15] have determined circadian Dbp
expression in whole pancreas extracts and assumed food to be
the dominant zeitgeber for this organ, as well as for the liver.
Our data, which indicate expression of Dbp within the islet of
Langerhans and INS1 cells, also indicate a functional output
from an endogenous islet-based oscillator and substantiate the
observed cyclic pattern of insulin release from isolated islets
[17]. The orphan receptor Rev-erbK, which generally acts as a
transcriptional repressor, is known to be rhythmically ex-
pressed in the SCN and liver as target of BMAL1/Clock-
mediated activation [21]. Rev-erbK transcript quantity also
varies with a high amplitude in the rat pancreas according
to our data. REV-ERBK, which is supposedly a major cir-
cadian regulator of Bmal1 expression, is concomitantly the
recipient of the PER-mediated negative output [21]. In accor-
dance with this assumption Bmal1 transcripts are at a mini-
mum in the pancreas when the Rev-erbK transcription level is
at its maximum.
In contrast to the CCO in the SCN, the amplitude of the
peripheral oscillators is dampened after a few cycles [31] once
removed from the in£uence of the SCN. Furthermore, the
expression pattern of the peripheral oscillators is delayed by
several hours compared to the CCO [32]. For the pancreatic
island, the self-sustained rhythm seems to last for several days
in an ex vivo situation without dampening of the amplitude
[17]. Future work will be aimed at elucidating islet-speci¢c
entraining cues and their role for regulating islet-linked func-
tions such as insulin and glucagon release.
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